Chiome Bioscience Inc. [4583.T]

TOKYO, May 14 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported non-consolidated results for Q1 FY2026 (ending December 2026).

Revenue was ¥150 million (+6.1% YoY). operating profit was ¥232 million.

Net profit was ¥233 million. Total assets stood at ¥1.7 billion with an equity ratio of 78.0%.

Financial results — FY2026/12 (consolidated)

MetricCurrentYoY
Revenue¥147M+6.1%
Operating profit¥-232Mn/a
Net profit¥-233Mn/a

Source: TDNet filing · Figures in millions of yen

Original Disclosure (PDF)

🟢 Confidence: High AI-translated content.